Gene · 54
Papers2,683
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,683
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Postoperative changes in bone mineral density and their determinants after knee arthroplasty for osteoarthritis. | J Orthop Sci | 2026 | 42230205 | PubTator, text mining | PubMed |
| Synergistic Efficacy of Calcitriol Combined with Denosumab versus Calcitriol Alone in Postmenopausal Osteoporosis: A Retrospective Cohort Study. | Int J Womens Health | 2026 | 42212302 | PubTator, text mining | PubMed |
| Romosozumab Achieves Consistent Lumbar Spine BMD Gains Across All BMI Categories: The Apparent Enhanced Response in Underweight Patients is a Mathematical Artifact of Percentage Change. | Calcif Tissue Int | 2026 | 42203994 | PubTator, text mining | PubMed |
| The Association Between Longitudinal Changes in TRACP-5b and Bone Metastasis Progression During Osimertinib Therapy. | Anticancer Res | 2026 | 42203350 | PubTator, text mining | PubMed |
Context-Dependent Association Between Serum 25-Hydroxyvitamin D and Romosozumab Bone Mineral Density Response: A Stratified Analysis by Renal Function Category and Prior Treatment History in a Real-World Japanese Cohort. | Nutrients | 2026 | 42197102 | PubTator, text mining | PubMed |
HECTD4 in human umbilical cord mesenchymal stem cells-derived exosomes alleviates osteoclast differentiation in osteoporosis progression by suppressing RANK m6A modification via promoting METTL3 ubiquitination. | J Mol Histol | 2026 | 42141331 | PubTator, text mining | PubMed |
| Impact of oral glucocorticoids on the effectiveness of romosozumab: the multicenter OASIS cohort study. | Osteoporos Int | 2026 | 42101658 | PubTator, text mining | PubMed |
| Optimizing bone health in lymphoma survivors: denosumab superiority to alendronate for R-CHOP-like therapy (the DENOSULY phase III randomized controlled trial). | Haematologica | 2026 | 42095246 | PubTator, text mining | PubMed |
| Oral Inflammatory Lesions and Bone Turnover Biomarkers (Dkk-1 and TRAP-5B) in Patients with ENT Cancer: A Radiological and Clinical Case-Control Study. | Medicina (Kaunas) | 2026 | 42075541 | PubTator, text mining | PubMed |
| Expanding the Genotypic and Phenotypic Spectrum of SPENCDI: A Novel ACP5 Variant and Literature Review. | Genes (Basel) | 2026 | 42074507 | PubTator, text mining | PubMed |
| Diagnostic Accuracy of Bone Turnover Markers in Patients With CKD: A Systematic Review and Meta-Analysis. | Kidney Med | 2026 | 42004660 | PubTator, text mining | PubMed |
| Trabecular bone score and bone metabolism markers in middle-aged and older female patients with distal radius fractures. | J Clin Densitom | 2026 | 41996978 | PubTator, text mining | PubMed |
| Janus kinase inhibitor therapy for the treatment of spondyloenchondrodysplasia with immune dysregulation due to novel ACP5 variants: a multicenter study. | Front Immunol | 2026 | 41993173 | PubTator, text mining | PubMed |
| LILRB1 Is a Prognostic-Related Biomarker Correlated With Immune Infiltration in Head-Neck Squamous Cell Carcinoma. | Cancer Med | 2026 | 41879001 | PubTator, text mining | PubMed |
| Associations of Blood Biomarkers of Bone Turnover with Static Histomorphometry Parameters at the Hip in Patients with Chronic Kidney Disease Undergoing Surgery for Hip Fracture. | medRxiv | 2026 | 41867173 | PubTator, text mining | PubMed |
| KLRG1 defines a distinct tumor-infiltrating granzyme K+ CD8 + T cell population. | J Cancer Res Clin Oncol | 2026 | 41857425 | PubTator, text mining | PubMed |
| Genetic and phenotypic landscape of monogenic lupus: insights from an international cohort. | Lupus Sci Med | 2026 | 41850754 | PubTator, text mining | PubMed |
| Distribution and Characteristics of Fall Risk Index-21 Scores in Patients with Fall-Related Hip Fractures. | J Bone Metab | 2026 | 41850322 | PubTator, text mining | PubMed |
| Mycobacterial metallophosphatase MmpE acts as a nucleomodulin to regulate host gene expression and promote intracellular survival. | Elife | 2026 | 41848417 | PubTator, text mining | PubMed |
| The characterization of RUNX1-mediated macrophage polarization requires a multidimensional perspective beyond the M1/M2 binary. | Inflamm Res | 2026 | 41843115 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54/papers?page=3